This survey conducted by the authors examined factors of Roger’s diffusion of innovation theory related to adopting machine learning (ML) and artificial intelligence (AI) in the bio/pharmaceutical manufacturing industry. The sample included industry leaders and bio/pharmaceutical professionals with experience in regulatory affairs, product development, and commercial operations at FDA-regulated bio/pharmaceutical companies. Participants responded to a survey administered with a direct link for confidentiality. Respondents were asked 44 questions on the adoption challenges of ML and AI practices in bio/pharma manufacturing.
